{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:29:50Z","timestamp":1761863390764,"version":"build-2065373602"},"reference-count":22,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","primary-care-diabetes.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Primary Care Diabetes"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.pcd.2015.01.011","type":"journal-article","created":{"date-parts":[[2015,2,17]],"date-time":"2015-02-17T22:38:27Z","timestamp":1424212707000},"page":"377-384","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Treatment persistence after initiating basal insulin in type 2 diabetes patients: A primary care database analysis"],"prefix":"10.1016","volume":"9","author":[{"given":"Stefan","family":"Pscherer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Engels","family":"Chou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franz-Werner","family":"Dippel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"Rathmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karel","family":"Kostev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pcd.2015.01.011_bib0115","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)","volume":"352","author":"UK Prospective Diabetes Study (UKPDS) Group","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.pcd.2015.01.011_bib0120","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s00125-012-2534-0","article-title":"Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"55","author":"Inzucchi","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.pcd.2015.01.011_bib0125","first-page":"CD006383","article-title":"Insulin detemir versus insulin glargine for type 2 diabetes mellitus","volume":"7","author":"Swinnen","year":"2011","journal-title":"Cochrane Database Syst. Rev."},{"year":"2009","series-title":"Long-acting insulin analogues in the treatment of type 2 diabetes. Executive summary of final report A05-03. Version 1.1","author":"Institute for Quality and Efficiency in Health Care","key":"10.1016\/j.pcd.2015.01.011_bib0130"},{"key":"10.1016\/j.pcd.2015.01.011_bib0135","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.2337\/diacare.27.5.1218","article-title":"A systematic review of adherence with medications for diabetes","volume":"27","author":"Cramer","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pcd.2015.01.011_bib0140","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1524-4733.2007.00213.x","article-title":"Medication compliance and persistence: terminology and definitions","volume":"11","author":"Cramer","year":"2008","journal-title":"Value Health"},{"key":"10.1016\/j.pcd.2015.01.011_bib0145","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s12325-014-0120-1","article-title":"Much ado about nothing? A real-world study of patients with type 2 diabetes switching basal insulin analogs","volume":"31","author":"Wei","year":"2014","journal-title":"Adv. Ther."},{"key":"10.1016\/j.pcd.2015.01.011_bib0150","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.clinthera.2009.03.005","article-title":"A comparison of insulin use, glycemic control, and health care costs with insulin detemir and insulin glargine in insulin-naive patients with type 2 diabetes","volume":"31","author":"Borah","year":"2009","journal-title":"Clin. Ther."},{"key":"10.1016\/j.pcd.2015.01.011_bib0155","doi-asserted-by":"crossref","first-page":"617","DOI":"10.5414\/CPP47617","article-title":"Validity and representativeness of the \u201cDisease Analyzer\u201d patient database for use in pharmacoepidemiological and pharmacoeconomic studies","volume":"47","author":"Becher","year":"2009","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"10.1016\/j.pcd.2015.01.011_bib0160","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining co-morbidities in ICD-9-CM and ICD-10 administrative data","volume":"43","author":"Quan","year":"2005","journal-title":"Med. Care"},{"key":"10.1016\/j.pcd.2015.01.011_bib0165","first-page":"54","article-title":"Good practice of secondary data analysis, first revision","volume":"70","author":"Swart","year":"2008","journal-title":"Gesundheitswesen"},{"key":"10.1016\/j.pcd.2015.01.011_bib0170","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1046\/j.1524-4733.2003.00242.x","article-title":"A checklist for retrospective database studies \u2013 report from the ISPOR task force on retrospective databases","volume":"6","author":"Motheral","year":"2003","journal-title":"Value Health"},{"key":"10.1016\/j.pcd.2015.01.011_bib0175","doi-asserted-by":"crossref","first-page":"52","DOI":"10.4158\/EP13159.OR","article-title":"Real-world insulin treatment persistence among patients with type 2 diabetes","volume":"20","author":"Wei","year":"2014","journal-title":"Endocr. Pract."},{"key":"10.1016\/j.pcd.2015.01.011_bib0180","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1185\/03007995.2013.811403","article-title":"Real-world comparative outcomes of US type 2 diabetes patients initiating analog basal insulin therapy","volume":"29","author":"Davis","year":"2013","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.pcd.2015.01.011_bib0185","doi-asserted-by":"crossref","first-page":"24","DOI":"10.5414\/CP201572","article-title":"Treatment duration (persistence) of basal insulin supported oral therapy (BOT) in type-2 diabetic patients: comparison of insulin glargine with NPH insulin","volume":"50","author":"Quinzler","year":"2012","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"10.1016\/j.pcd.2015.01.011_bib0190","doi-asserted-by":"crossref","first-page":"761","DOI":"10.5414\/CPP48761","article-title":"Different persistence on initial basal supported oral therapy in type 2 diabetics is associated with unequal distributions of insulin treatment regimens under real-life conditions in Germany","volume":"48","author":"Pfohl","year":"2010","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"10.1016\/j.pcd.2015.01.011_bib0195","doi-asserted-by":"crossref","DOI":"10.1007\/s13300-014-0068-9","article-title":"Metabolic effects of basal or premixed insulin treatment in 5077 insulin-na\u00efve type 2 diabetes patients: registry-based observational study in clinical practice","author":"Eliasson","year":"2014","journal-title":"Diabetes Ther."},{"key":"10.1016\/j.pcd.2015.01.011_bib0200","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1177\/193229681300700527","article-title":"Different injection frequencies of basal insulins in type 2 diabetes patients under real-life conditions: a retrospective database analysis","volume":"7","author":"Rathmann","year":"2013","journal-title":"J. Diabetes Sci. Technol."},{"key":"10.1016\/j.pcd.2015.01.011_bib0205","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.cardiores.2003.11.027","article-title":"The development of myocardial insulin resistance in conscious dogs with advanced dilated cardiomyopathy","volume":"61","author":"Nikolaidis","year":"2004","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.pcd.2015.01.011_bib0210","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/eurjhf\/hfq204","article-title":"Improved diabetic control in advanced heart failure patients treated with left ventricular assist devices","volume":"13","author":"Uriel","year":"2011","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.pcd.2015.01.011_bib0215","doi-asserted-by":"crossref","DOI":"10.1111\/dom.12280","article-title":"Mortality risk with sulphonylureas compared to metformin","author":"Holden","year":"2014","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.pcd.2015.01.011_bib0220","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1111\/dme.12232","article-title":"Sulphonylureas and risk of cardiovascular disease: systematic review and meta-analysis","volume":"30","author":"Phung","year":"2013","journal-title":"Diabet. Med."}],"container-title":["Primary Care Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1751991815000121?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1751991815000121?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T23:55:17Z","timestamp":1761695717000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1751991815000121"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S1751991815000121"],"URL":"https:\/\/doi.org\/10.1016\/j.pcd.2015.01.011","relation":{},"ISSN":["1751-9918"],"issn-type":[{"type":"print","value":"1751-9918"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment persistence after initiating basal insulin in type 2 diabetes patients: A primary care database analysis","name":"articletitle","label":"Article Title"},{"value":"Primary Care Diabetes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pcd.2015.01.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Primary Care Diabetes Europe. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}